Telemetry Investments, L.L.C. Checkpoint Therapeutics, Inc. Transaction History

Telemetry Investments, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.97 - $1.77 $43,650 - $79,650	-45,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.53 - $3.25 $30,600 - $65,000	-20,000 Reduced 30.77%	45,000 $80,000
Q4 2021 Feb 14, 2022	SELL	$2.68 - $4.46 $13,400 - $22,300	-5,000 Reduced 7.14%	65,000 $202,000
Q3 2021 Nov 15, 2021	BUY	$2.5 - $3.53 $175,000 - $247,100	70,000 New	70,000 $231,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $191M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.